ClinicalTrials.gov
public full text
Public Domain
Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
breast-cancerbreast-neoplasmscolon-cancercolorectal-cancercolorectal-carcinomacolorectal-neoplasmsrectal-cancer
The purpose of this trial is to determine the safety of hMN14 at different dose levels in the treatment of either colorectal or breast cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer#1030785
- Pilot Window of Opportunity Trial (POET)#1102498
- A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors#830310
- Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer#1113532
- Scope Pilot Research Study#845811
Record · ID 804554
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive